Trevor Wolfe started with Rain in January 2019 as Director of Corporate Finance. He joined from Centerview Partners where he advised public and private life science companies on a broad range of complex strategic and financial issues and transactions, including mergers, acquisitions, divestitures, partnerships, defense, and structured financings. Notable transactions include Ironwood Pharmaceutical’s separation of their pipeline assets (Cyclerion) and commercial assets, XenoPort’s $467mm sale to Arbor Pharmaceuticals and Ultragenyx’s $151mm acquisition of Dimension Therapeutics. Prior to his time at Centerview, Mr. Wolfe spent a year executing financing transactions at Cowen Group for life science companies. He holds a B.A. in Finance from Southern Methodist University and lives in San Francisco.